Daniel Kisner, M.D.
Partner, Aberdare Ventures

Dr. Kisner joined Aberdare Ventures in 2002 from Caliper Technologies where he was President and CEO. Dr. Kisner is the current Chairman of the Board of Caliper Life Sciences, (NASDAQ: CALP), the market leader in lab-on-a-chip technologies. Dr. Kisner joined Caliper from Isis Pharmaceuticals where he was President and Chief Operating Officer. He had previously been responsible for business development, product development, and manufacturing as Executive Vice President. Prior to joining Isis, Dr. Kisner was Division Vice President of Pharmaceutical Development for Abbott Laboratories where he led a team of 650 scientists, physicians and support personnel. His responsibilities included the preclinical and clinical development of all Abbott Laboratories' ethical pharmaceuticals. Dr. Kisner has also held the position of Vice President of Clinical Research and Development for International Studies for SmithKline Beckman Corporation and has had a tenured position in the Division of Oncology at The University of Texas, San Antonio School of Medicine. Dr. Kisner is certified by the American Board of Internal Medicine and certified in Medical Oncology. He is the author of more than 50 scientific papers and 40 abstracts in clinical journals and textbooks. Dr. Kisner received his M.D. from Georgetown University in 1972. In addition to Mpex and Caliper, Dr. Kisner is a director of Sequoia Pharmaceuticals, Avera Pharmaceuticals, and TolerRx, Inc.